2016-08-10 21:47:43 UTC

DDSEP 8® Features Latest HCV Updates

Aug. 11, 2016

Contributor Dr. Carl Berg offers his take on why the latest DDSEP offering is among the best.

By Carl L. Berg, MD, professor of medicine at Duke University, Durham, NC, and DDSEP® 8 co-author of Chapter 5: Viral Hepatitis. Dr. Berg summarized some of his favorite features of our latest DDSEP installment. 

The viral hepatitis chapter in Digestive Diseases Self Education Program® 8 (DDSEP8) was extensively rewritten since DDSEP 7 in order to reflect the many advances in HCV therapy. It provides important foundational information regarding treatment combinations, durations and drug-drug interactions.

In addition to the content itself, the information is presented in tabular form throughout the books for easy access and to allow clinicians to efficiently incorporate this information into practice. Many new references were also added, reflecting the inclusion of the most recent original clinical observations and most up-to-date practice guidelines. 

Key references are also highlighted at the end of the chapter to direct the reader to the most updated sources of clinically relevant information. This should help both the clinician in practice and serve as a key guide for the physician preparing for board certification or re-certification. The continued presence of the Pearls and Pitfalls section also allows for a quick self-assessment of knowledge and can help identify areas of need for further study as one prepares for board examination. The chapter was edited all of the way up to press time in order to incorporate the most up-to-date information in this rapidly changing field, reflecting our commitment to make its contents as relevant as possible. 

To purchase the latest installment of DDSEP, visit http://buyddsep8.gastro.org/. Just interested in the viral hepatitis chapter? Visit http://buyddsep8.gastro.org/chapters to learn more. 

More on Autoimmune Hepatitis Liver Disease

Inflammation Contributes to the Development of Anemia

Nov. 17, 2016

The process involves increased liver expression of a microRNA that reduces production of erythropoietin in the kidney, according to a study in Gastroenterology.

Hydrazine Shows Potential as Therapy for Acute Alcoholic Liver Disease

July 5, 2016

New from CMGH: hydrazine protected mice from the damaging effects of alcohol.

2016-2017 GI Resource Catalog

April 26, 2016

Whether it’s the latest in clinical education, cutting-edge science or navigating the future of medicine, AGA has you covered. Find resources to address all of your professional needs in the GI Resource Catalog.